Huh? The market is getting KILLED. Stocks that have been on the biggest runs often take the biggest hits in a heavy correction. That's your reason for the drop.
Why would anybody short such a high momentum stock right now? There's so much easier money to be made shorting other stocks. Fundamentals don't mean an awful lot in today's market. Not sure why so many fail to recognize that.
Well, if NBC is correct, then it can't be SRPT's drug. We don't have a vaccine. But maybe NBC simply meant to say trial. If it is in fact a vaccine, you can be all but certain that it's GSK's vaccine.
For the past few months, they've been rather quiet. The last couple of days has seen a flurry of postings. It could just be because of WMS, but it's something that caught my attention. Here's hoping the FDA is listening.
Wondering if TWTR could end up going on a TSLA-like run (from last year) after its upcoming earnings. Thoughts on the likelihood of that? The stock has been amazingly strong during this downturn, which leads me to believe that is a positive indicator for earnings.
This guy is a mindless pumper. Ignore him. He's as bad as the idiot bashers.
Um, there have been hundreds of humans who've received CMRX's drug, and not one of them has had any severe side effects. You clearly aren't aware that brincidofovir is an antiviral currently in multiple trials to treat many kinds of viruses.
Do some DD before making ignorant comments.
You're guessing correctly. He was already 10 days into symptoms before any treatment began. Doubtful any drug could have stopped the Ebola.
That wouldn't have saved him. Does nobody do any DD on TKM-Ebola? It needs to be delivered WITHIN 5 DAYS of symptoms to be effective.
Please. He'd have died with TKMR too. He was too far gone by the time the drug was administered (10 days after getting sick). If you read the literature on TKMR, you'd know it needs to be administered within 5 days of becoming sick.
I'm not defending the CEO. I'm simply suggesting that the drop in price has an awful lot to do with the wretched market as well. You could make the case that SRPT is taking an even bigger beating than it otherwise would because of the hatred the market has for the CEO. On that point, I wouldn't argue with you. The market's mistrust of the CEO amplifies what would otherwise be a more normal drop, analogous to the rest of the market. In other words, I agree that the CEO has a negative effect on the stock price.
Um, nobody invests in emerging biotechs based on EPS numbers. They invest based on the possibility of future returns.
The market is as much to blame for the beating SRPT is currently undergoing as anything else. Lots of fear that we're entering a major correction. If so, the drop isn't done.